Trends and determinants of severe morbidity in HIV-infected patients:: The ANRS CO3 Aquitaine Cohort, 2000-2004

被引:50
作者
Bonnet, Fabrice
Chene, G.
Thiebaut, R.
Dupon, M.
Lawson-Ayayi, S.
Pellegrin, J. L.
Dabis, F.
Morlat, P.
机构
[1] CHU Bordeaux, Serv Med Interne & Malad Infect, F-33075 Bordeaux, France
[2] INSERM, U593, Bordeaux, France
[3] Univ Victor Segalen, ISPED, Bordeaux, France
[4] INSERM, U875, Bordeaux, France
[5] CHU Bordeaux, CISIH, Bordeaux, France
关键词
bacterial infections; cancers; epidemiology; HIV; morbidity; opportunistic infections;
D O I
10.1111/j.1468-1293.2007.00508.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective The aim of the study was to characterize the causes, trends and determinants of severe morbidity in a large cohort of HIV-infected patients between 2000 and 2004. Method Severe morbid events were defined as medical events associated with hospitalization or death. Epidemiological and biological data were recorded at the time of the morbid event. Trends were estimated using Poisson regression. Results Among 3863 individuals followed between 2000 and 2004, 1186 experienced one or more severe events, resulting in 1854 hospitalizations or deaths. The severe events recorded included bacterial infections (21%), AIDS events (20%), psychiatric events (10%), cardiovascular events (9%), digestive events including cirrhosis (7%), viral infections (6%) and non-AIDS cancers (5%). Between 2000 and 2004, the incidence rate of AIDS events decreased from 60 to 20 per 1000 person-years, that of bacterial infections decreased from 45 to 24 per 1000 person-years, and that of psychiatric events decreased from 26 to 14 per 1000 person-years (all P < 0.01), whereas the incidences of cardiovascular events and of non-AIDS cancers remained stable at 14 and 10 per 1000 person-years, on average, respectively. Conclusion Severe morbidity has shifted from AIDS-related to non-AIDS-related events during the course of HIV infection in developed countries. Limiting endpoints to AIDS events and death is insufficient to describe HIV disease progression in the era of combination antiretroviral therapy.
引用
收藏
页码:547 / 554
页数:8
相关论文
共 22 条
  • [1] [Anonymous], MMWR RECOMM REP
  • [2] [Anonymous], 1993, INT CLASS DIS
  • [3] Decreased morbidity and use of hospital services in English HIV-infected individuals with increased uptake of anti-retroviral therapy 1996-1997
    Beck, EJ
    Mandalia, S
    Williams, I
    Power, A
    Newson, R
    Molesworth, A
    Barlow, D
    Easterbrook, P
    Fisher, M
    Innes, J
    Kinghorn, G
    Mandel, B
    Pozniak, A
    Tang, A
    Tomlinson, D
    [J]. AIDS, 1999, 13 (15) : 2157 - 2164
  • [4] Bénard A, 2006, INT J TUBERC LUNG D, V10, P378
  • [5] Tobacco addiction and HIV infection: Toward the implementation of cessation programs. ANRS CO3 Aquitaine Cohort
    Benard, Antoine
    Bonnet, Fabrice
    Tessier, Jean-Francois
    Fossoux, Helene
    Dupon, Michel
    Mercie, Patrick
    Ragnaud, Jean-Marie
    Viallard, Jean-Francois
    Dabis, Francois
    Chene, Genevieve
    [J]. AIDS PATIENT CARE AND STDS, 2007, 21 (07) : 458 - 468
  • [6] Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients
    Benhamou, Y
    Bochet, M
    Di Martino, V
    Charlotte, F
    Azria, F
    Coutellier, A
    Vidaud, M
    Bricaire, F
    Opolon, P
    Katlama, C
    Poynard, T
    [J]. HEPATOLOGY, 1999, 30 (04) : 1054 - 1058
  • [7] Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States
    Bing, EG
    Burnam, A
    Longshore, D
    Fleishman, JA
    Sherbourne, CD
    London, AS
    Turner, BJ
    Eggan, F
    Beckman, R
    Vitiello, B
    Morton, SC
    Orlando, M
    Bozzette, SA
    Ortiz-Barron, L
    Shapiro, M
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 2001, 58 (08) : 721 - 728
  • [8] Bonnet F, 2002, HIV Med, V3, P195, DOI 10.1046/j.1468-1293.2002.00117.x
  • [9] Cancer risk in the swiss HIV cohort study: Associations with immunodeficiency, smoking, and highly active antiretroviral therapy
    Clifford, GM
    Polesel, J
    Rickenbach, M
    Dal Maso, L
    Keiser, O
    Kofler, A
    Rapiti, E
    Levi, F
    Jundt, G
    Fisch, T
    Bordoni, A
    De Weck, D
    Franceschi, S
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (06): : 425 - 432
  • [10] Gender and hospitalization patterns among HIV-Infected drug users before and after the availability of highly active antiretroviral therapy
    Floris-Moore, M
    Lo, YT
    Klein, RS
    Budner, N
    Gourevitch, MN
    Moskaleva, G
    Schoenbaum, EE
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 34 (03) : 331 - 337